Granules Executive and Leadership Team

Kamal Mandan, the Chief Financial Officer at Granules, manages the fiscal health and capital allocation strategies for the organization. Overseeing financial reporting and internal audits, the Chief Financial Officer ensures transparency and regulatory adherence. This leadership role involves analyzing market trends to guide investment in new pharmaceutical technologies. By monitoring cash flow and debt structures, Kamal Mandan directly impacts the company's long-term financial stability. Mandan collaborates with the executive team to align budgetary resources with strategic growth objectives. Through precise financial forecasting, the Chief Financial Officer mitigates risks associated with global market volatility. This fiscal discipline supports the expansion of manufacturing capabilities and research initiatives. Mandan maintains strong relationships with investors and financial institutions to secure necessary capital for future projects. Ultimately, the Chief Financial Officer provides the economic foundation required for sustained growth and operational excellence within the competitive pharmaceutical landscape.

Mukesh Surana, the Global Chief Financial Officer at Granules, directs international financial strategy and cross-border fiscal operations. Overseeing the consolidation of global accounts, the Global Chief Financial Officer ensures compliance with diverse international accounting standards. This leadership role involves managing currency risk and optimizing tax structures across multiple jurisdictions. By coordinating global financial planning, Mukesh Surana directly impacts the company's international market expansion. Surana collaborates with regional leaders to ensure that financial resources support local growth targets. Through the implementation of global financial controls, the Global Chief Financial Officer maintains the integrity of the company's international assets. This strategic focus supports the company's presence in key global markets and enhances overall shareholder value. Surana monitors global economic indicators to adjust financial strategies in real-time. Ultimately, the Global Chief Financial Officer provides the financial architecture necessary for the company to thrive as a global pharmaceutical entity.

Jai Velusamy, the Chief Operating Officer at Granules, directs all internal manufacturing processes and supply chain logistics. Overseeing the production of API and finished dosages, the Chief Operating Officer ensures operational efficiency across all facilities. This leadership role involves optimizing vertical integration to maintain high-quality standards for global pharmaceutical markets. By streamlining production workflows, Jai Velusamy directly impacts the company's ability to meet rising international demand. Velusamy manages cross-functional teams to reduce manufacturing lead times while maintaining strict regulatory compliance. Through rigorous oversight of plant performance, the Chief Operating Officer secures consistent output levels. This operational focus supports the broader mission of delivering affordable, high-quality medication to diverse patient populations. Velusamy maintains alignment with the Board regarding capacity expansion and infrastructure investments. Ultimately, the Chief Operating Officer drives the technical and logistical success of the entire manufacturing ecosystem.

Vinod Parur, the President & Chief Human Resources Officer at Granules, directs talent acquisition and organizational development strategies. Overseeing the cultivation of a high-performance culture, the President & Chief Human Resources Officer ensures the alignment of human capital with business goals. This leadership role involves designing training programs that enhance technical expertise in pharmaceutical manufacturing. By fostering employee engagement, Vinod Parur directly impacts the company's retention rates and operational productivity. Parur manages compensation structures and performance management systems to attract top industry talent. Through the development of leadership pipelines, the President & Chief Human Resources Officer secures the future of the organization. This focus on human capital supports the company's mission by ensuring that the workforce remains capable of meeting complex manufacturing challenges. Parur collaborates with other executives to promote a culture of safety and innovation. Ultimately, the President & Chief Human Resources Officer drives the organizational health required for long-term success.

Vijay Raghavan, the Global President, Portfolio at Granules, directs the development and lifecycle management of the entire product range. Overseeing the expansion of the API and finished dosage portfolio, the Global President, Portfolio ensures that product offerings meet evolving market needs. This leadership role involves identifying new therapeutic areas for growth and managing the pipeline of specialty products. By analyzing market demand, Vijay Raghavan directly impacts the company's revenue growth and market positioning. Raghavan collaborates with R&D and marketing teams to bring high-quality products to market efficiently. Through the strategic management of the product mix, the Global President, Portfolio maximizes profitability and customer satisfaction. This focus on portfolio diversification supports the company's mission to provide comprehensive pharmaceutical solutions. Raghavan monitors global regulatory trends to ensure that the product portfolio remains compliant and competitive. Ultimately, the Global President, Portfolio drives the commercial success of the company's diverse product offerings.

Ramraj Rangarajalu, the President, Formulation Operations (India) at Granules, directs the manufacturing activities for finished dosage forms within the domestic market. Overseeing the daily operations of formulation plants, the President, Formulation Operations (India) ensures that production targets are met with high quality. This leadership role involves managing the technical teams responsible for complex pharmaceutical formulations. By optimizing local manufacturing processes, Ramraj Rangarajalu directly impacts the company's domestic market share and operational reliability. Rangarajalu coordinates with quality assurance teams to maintain strict adherence to safety and efficacy standards. Through the implementation of lean manufacturing principles, the President, Formulation Operations (India) reduces waste and improves production speed. This operational focus supports the company's mission by ensuring a steady supply of essential medications. Rangarajalu manages the workforce to maintain high standards of operational excellence. Ultimately, the President, Formulation Operations (India) drives the efficiency and quality of the company's core formulation business.

Srinivas Pv, the Chief Technology Officer at Granules, architects the digital infrastructure and technical innovation roadmap. Overseeing the integration of advanced manufacturing software, the Chief Technology Officer ensures the modernization of production lines. This leadership role involves implementing data-driven solutions to enhance pharmaceutical formulation accuracy. By leveraging emerging technologies, Srinivas Pv directly impacts the company's competitive edge in the global market. Pv manages the IT department to secure critical data and streamline internal communication systems. Through the deployment of automated systems, the Chief Technology Officer increases overall manufacturing precision and output quality. This technical focus supports the company's commitment to innovation and customer-centric product development. Pv collaborates with the operations team to ensure seamless technology adoption across all manufacturing sites. Ultimately, the Chief Technology Officer drives the digital transformation necessary to maintain leadership in the high-growth pharmaceutical sector.

Sriram Chavali, the EA-Chief of Staff, Directorate at Granules, coordinates strategic initiatives and executive communications. Overseeing the flow of information between the Directorate and departmental heads, the EA-Chief of Staff, Directorate ensures alignment with corporate objectives. This leadership role involves managing high-priority projects that require cross-functional collaboration. By facilitating decision-making processes, Sriram Chavali directly impacts the speed and effectiveness of executive actions. Chavali organizes board meetings and tracks the progress of key performance indicators across the organization. Through the management of administrative workflows, the EA-Chief of Staff, Directorate optimizes the productivity of the senior leadership team. This role supports the company's mission by ensuring that strategic goals remain the primary focus of all operational activities. Chavali maintains a comprehensive view of the business to identify potential bottlenecks and opportunities for improvement. Ultimately, the EA-Chief of Staff, Directorate secures organizational cohesion and strategic focus.